Testicular seminoma: Results of treatment at the Northern Israel oncology center

M. Stein; M. Steiner; A. Koten; Y. Cohen; E. Robinson

doi:10.1159/000226341

Testicular seminoma: Results of treatment at the Northern Israel oncology center

M. Stein
, M. Steiner
, A. Koten
, Y. Cohen
, E. Robinson

Internal Medicine Division

Research output: Contribution to journal › Article › peer-review

7 Citations (Web of Science)

Abstract

The survival, and the patterns and mechanisms of failure of 41 patients with pure testicular seminoma treated at the Northern Israel Oncology Center from 1968 to 1983 were analyzed. The actuarial 5-year survival of all patients was 85.4% and of stage I patients, 92.2%. Treatment failures were analyzed. The following conclusions were reached: in order to increase the cure rate, the use of combination chemotherapy as the initial treatment modality in advanced seminoma is recommended. In cases of transscrotal approach, the scrotum should be irradiated. Adjuvant mediastinal irradiation is not needed.

Original language	English
Pages (from-to)	89-92
Number of pages	4
Journal	Oncology
Volume	43
Issue number	2
DOIs	https://doi.org/10.1159/000226341
State	Published - 1 Jan 1986

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1159/000226341

Cite this

@article{17e2e3e53d2c4bd59fc65fb80d399739,

title = "Testicular seminoma: Results of treatment at the Northern Israel oncology center",

abstract = "The survival, and the patterns and mechanisms of failure of 41 patients with pure testicular seminoma treated at the Northern Israel Oncology Center from 1968 to 1983 were analyzed. The actuarial 5-year survival of all patients was 85.4\% and of stage I patients, 92.2\%. Treatment failures were analyzed. The following conclusions were reached: in order to increase the cure rate, the use of combination chemotherapy as the initial treatment modality in advanced seminoma is recommended. In cases of transscrotal approach, the scrotum should be irradiated. Adjuvant mediastinal irradiation is not needed.",

author = "M. Stein and M. Steiner and A. Koten and Y. Cohen and E. Robinson",

year = "1986",

month = jan,

day = "1",

doi = "10.1159/000226341",

language = "English",

volume = "43",

pages = "89--92",

journal = "Oncology",

issn = "0030-2414",

publisher = "S. Karger AG",

number = "2",

}

TY - JOUR

T1 - Testicular seminoma

T2 - Results of treatment at the Northern Israel oncology center

AU - Stein, M.

AU - Steiner, M.

AU - Koten, A.

AU - Cohen, Y.

AU - Robinson, E.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - The survival, and the patterns and mechanisms of failure of 41 patients with pure testicular seminoma treated at the Northern Israel Oncology Center from 1968 to 1983 were analyzed. The actuarial 5-year survival of all patients was 85.4% and of stage I patients, 92.2%. Treatment failures were analyzed. The following conclusions were reached: in order to increase the cure rate, the use of combination chemotherapy as the initial treatment modality in advanced seminoma is recommended. In cases of transscrotal approach, the scrotum should be irradiated. Adjuvant mediastinal irradiation is not needed.

AB - The survival, and the patterns and mechanisms of failure of 41 patients with pure testicular seminoma treated at the Northern Israel Oncology Center from 1968 to 1983 were analyzed. The actuarial 5-year survival of all patients was 85.4% and of stage I patients, 92.2%. Treatment failures were analyzed. The following conclusions were reached: in order to increase the cure rate, the use of combination chemotherapy as the initial treatment modality in advanced seminoma is recommended. In cases of transscrotal approach, the scrotum should be irradiated. Adjuvant mediastinal irradiation is not needed.

UR - https://www.scopus.com/pages/publications/0022588437

U2 - 10.1159/000226341

DO - 10.1159/000226341

M3 - Article

AN - SCOPUS:0022588437

SN - 0030-2414

VL - 43

SP - 89

EP - 92

JO - Oncology

JF - Oncology

IS - 2

ER -

Testicular seminoma: Results of treatment at the Northern Israel oncology center

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this